Stryker's Biotech Division Receives FDA Warning Letter
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Stryker's Biotech Division Receives FDA Warning Letter
2 May 08, 16:58
KALAMAZOO, Mich., May 2 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that its Biotech division has received a warning letter ...
more

 

 
© 2007 nafdacnigeria.org